← Back
$SONN All transactions

Sonnet BioTherapeutics Holdings, Inc.

A

$ Value

Shares

4,000

Price

Filed

Jul 15

Insider

Name

Dyrness Albert D.

Title

CIK

0001664801

Roles

Director

Transaction Details

Transaction Date

2023-07-11

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

4,537

Footnotes

On July 11, 2025, the Reporting Person was granted 4,000 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest as to 100% of the restricted stock units on the earlier of (i) January 8, 2026, or (ii) the date of a "Change in Control" (as defined under the Issuer's 2020 Omnibus Equity Incentive Plan). | Includes unvested restricted stock units. | All amounts reflect the Issuer's 1:22 reverse stock split effective as of August 31, 2023 and 1:8 reverse stock split effective as of September 30, 2024.

Filing Info

Accession No.

0001641172-25-019785

Form Type

4

Issuer CIK

0001106838

Dyrness Albert D.'s History

Date Ticker Type Value
2026-02-09 PURR A $0
2025-12-02 SONN D
2025-12-02 PURR J
2023-07-11 SONN A

Other Insiders at SONN (90d)

No other insider activity at this issuer in the last 90 days.